Table 2.

Unadjusted 90-Day Outcomes After Completing Clostridioides difficile Treatment

Outcome	BEZ (n = 53)	SoC (n = 53)	P Value
rCDI	6 (11)	23 (43)	<.001
All-cause hospital readmission	21 (40)	34 (64)	.011
Heart failure exacerbationa	1 (2.9)	1 (7.1)	.503
Infusion-related reactionb	1 (1.9)	…
All-cause mortality	1 (1.9)	0	.999

Data are presented as No. (%) unless otherwise indicated.

Abbreviations: BEZ, bezlotoxumab; rCDI, recurrent Clostridioides difficile infection; SoC, standard of care.

^aPercentages are of those with underlying heart failure.

^bSafety analysis included all patients that received any BEZ administration (n = 54).